The morbidity and mortality of lung cancer and esophageal cancer in my country continue to increase. Traditional treatment programs have limited curative effects and low effective rates. In addition, patients whose treatment fails are in poor physical condition and can hardly bear follow-up treatment. The trial and application of immune checkpoint preparations in thoracic tumors has opened a new chapter of hope. Based on this, Chengdu High-tech Medical Association held the "Academic Tour of Multidisciplinary Comprehensive Treatment of Thoracic Tumor" from September to October 2021.

The first academic tour was successfully held in Chengdu on September 4. The conference was opened by Professor Zhou Qinghua, Professor Huang Meijuan and Professor He Jintao. The opening speeches and conclusions were made by Professor Gong Youling, Professor He Lang, Professor Dai Tianyang, Professor Lan Haitao and Professor Li Hongmin around clinical cases related to the treatment of thoracic tumors. Wonderful explanation and analysis.

The second academic tour was successfully held in Chengdu on October 23. Professor Wang Yongsheng gave an opening speech and a summary. Professor Sun Jianguo, Professor Fu Junke, Professor Ma Zheng, etc. focused on the progress of immunotherapy in advanced NSCLC and launched a wonderful analysis.

In this academic tour of multidisciplinary comprehensive treatment of thoracic tumors, with the theme of "precise exploration and avoidance", two wonderful seminars on the diagnosis and treatment of thoracic tumors were carried out. The conference invited famous experts in the field of thoracic tumors from inside and outside the province. Experts conducted special lectures and discussions, providing an opportunity for academic exchanges for collaboration and exchanges among medical staff of various medical institutions inside and outside the province, and promoted the overall development of thoracic tumors inside and outside the province.